“Prostate cancer is a major cause of death among men worldwide.
Recent preclinical evidence implicates cannabinoids as powerful regulators of cell growth and differentiation, as well as potential anti-cancer agents.
The aim of this review was to evaluate the effect of cannabinoids on in vivo prostate cancer models.
We identified six studies that were all found to be based on in vivo/xenograft animal models.
All studies have reported that the treatment of prostate cancers in in vivo/xenograft models with various cannabinoids decreased the size of the tumor, the outcomes of which depended on the dose and length of treatment.
Within the limitation of these identified studies, cannabinoids were shown to reduce the size of prostate cancer tumors in animal models.”